BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6881095)

  • 1. Usefulness of Counterimmunoelectrophoresis for detecting toxin of Clostridium difficile.
    Ryan RW
    Am J Clin Pathol; 1983 Aug; 80(2):274-6. PubMed ID: 6881095
    [No Abstract]   [Full Text] [Related]  

  • 2. Problems associated with counterimmunoelectrophoresis assays for detecting Clostridium difficile toxin.
    West SE; Wilkins TD
    J Clin Microbiol; 1982 Feb; 15(2):347-9. PubMed ID: 7068832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved immunologic detection of Clostridium difficile antigen by counterimmunoelectrophoresis.
    Ryan RW; Kwasnik I; Tilton RC
    Diagn Microbiol Infect Dis; 1983 Mar; 1(1):59-63. PubMed ID: 6671366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of CIE for the detection of Clostridium difficile toxin in stool filtrates: laboratory and clinical correlation.
    Kurzynski TA; Cembrowski GS; Kimball JL
    Am J Clin Pathol; 1983 Mar; 79(3):370-4. PubMed ID: 6829506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of Clostridium difficile toxin by counterimmunoelectrophoresis: a note of caution.
    Poxton IR; Byrne MD
    J Clin Microbiol; 1981 Sep; 14(3):349. PubMed ID: 7287891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The non-value of counterimmunoelectrophoresis for the direct rapid detection of Clostridium difficile toxin in stool filtrates.
    Sands M; Yungbluth M; Sommers HM
    Am J Clin Pathol; 1983 Mar; 79(3):375-7. PubMed ID: 6829507
    [No Abstract]   [Full Text] [Related]  

  • 7. False-positive counterimmunoelectrophoresis tests for Clostridium difficile: the role of Clostridium bifermentans and Clostridium sordellii.
    Jarvis W; Nunez-Monteil O; Thompson F; Dowell V; Towns M; Morris G; Vogler W; Winton E; Hill E
    J Infect Dis; 1983 Dec; 148(6):1168-9. PubMed ID: 6655298
    [No Abstract]   [Full Text] [Related]  

  • 8. Varying results of counterimmunoelectrophoresis for the detection of Clostridium difficile toxins.
    Tilton RC; Ryan RW
    J Infect Dis; 1982 Sep; 146(3):449-50. PubMed ID: 7108287
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of age, sex, and diet on asymptomatic colonization of infants with Clostridium difficile.
    Cooperstock M; Riegle L; Woodruff CW; Onderdonk A
    J Clin Microbiol; 1983 May; 17(5):830-3. PubMed ID: 6863502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential value of repeat stool testing for Clostridium difficile stool toxin using enzyme immunoassay?
    Deshpande A; Pasupuleti V; Pant C; Hall G; Jain A
    Curr Med Res Opin; 2010 Nov; 26(11):2635-41. PubMed ID: 20923255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Counterimmunoelectrophoresis vs. cytotoxicity assay for the detection of Clostridium difficile toxin.
    Levine HG; Kennedy M; LaMont JT
    J Infect Dis; 1982 Mar; 145(3):398. PubMed ID: 7061887
    [No Abstract]   [Full Text] [Related]  

  • 12. Experimental studies of antibiotic associated colitis.
    Bartlett JG
    Scand J Infect Dis Suppl; 1980; (Suppl 22):11-5. PubMed ID: 6937944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clostridium difficile and its toxin in healthy neonates.
    Richardson SA; Alcock PA; Gray J
    Br Med J (Clin Res Ed); 1983 Sep; 287(6396):878. PubMed ID: 6412868
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of clinical, microbiologic, and clinicopathologic findings in horses positive and negative for Clostridium difficile infection.
    Ruby R; Magdesian KG; Kass PH
    J Am Vet Med Assoc; 2009 Mar; 234(6):777-84. PubMed ID: 19284345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of bacterial isolation, cytotoxicity assay, and counterimmunoelectrophoresis for the detection of Clostridium difficile and its toxin.
    Jarvis W; Nunez-Montiel O; Thompson F; Dowell V; Towns M; Morris G; Hill E
    J Infect Dis; 1983 Apr; 147(4):778. PubMed ID: 6842010
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clostridium difficile and its toxin in a series of cases of Crohn's disease and ulcerative colitis].
    Jonard PP; Fiasse R; Delmeee M; Vanheuverzwijn R; Dive C
    Acta Gastroenterol Belg; 1983; 46(5-6):220-9. PubMed ID: 6670447
    [No Abstract]   [Full Text] [Related]  

  • 17. Nosocomial-acquired and community-onset Clostridium difficile infection at an academic hospital in Italy: Epidemiology, recurrences and toxin genes distribution.
    Visconti V; Brunetti G; Cuomo MR; Giordano A; Raponi G
    J Infect Chemother; 2017 Nov; 23(11):763-768. PubMed ID: 28899610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory-based surveillance for vancomycin-resistant enterococci: utility of screening stool specimens submitted for Clostridium difficile toxin assay.
    Leber AL; Hindler JF; Kato EO; Bruckner DA; Pegues DA
    Infect Control Hosp Epidemiol; 2001 Mar; 22(3):160-4. PubMed ID: 11310695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clostridium difficile toxin A and other enteropathogens in stool specimens of children hospitalized due to acute diarrhoea].
    Rozkiewicz D; Zaremba ML; Fiedoruk K; Daniluk T; Sciepuk M; Kurzatkowska B; Sulik A; Ołdak E
    Przegl Epidemiol; 2005; 59(3):711-21. PubMed ID: 16433313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of two novel chemiluminescence immunoassays for the detection of Clostridium difficile glutamate dehydrogenase and toxin A&B.
    Blaich A; Frei R; Castellano C; Kiessling C; Geschke A; Rentsch KM; Egli A
    J Microbiol Methods; 2017 Apr; 135():63-65. PubMed ID: 28192156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.